ImmunologybioRxivPreprint
Paridiprubart inhibits TLR4-dependant NF-κB activation by multiple pathogens
Ramy Habashy Malty, Richard Hilbe, Sang Ahn…·Scott D. Gray‐Owen
This study shows that paridiprubart, a TLR4 inhibitor, suppresses NF-κB activation by multiple pathogens including SARS-CoV-2 and bacterial agents.
DOI 10.1101/2023.06.27.545921